Insulin pump therapy: A meta-analysis

Diabetes Care

Volumn 26, Issue 4, 2003, Pages 1079-1087

  Weissberg Benchell, Jill ^a,c   Antisdel Lomaglio, Jeanne ^b   Seshadri, Roopa ^a  

^a CHILDREN'S MEMORIAL HOSPITAL   (United States)

^b Cancer Support Center   (United States)

^c Box 10 ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOSE; GLYCOSYLATED HEMOGLOBIN; INSULIN;

AGE; ARTICLE; BODY WEIGHT; CLINICAL TRIAL; DIABETES MELLITUS; DIABETIC KETOACIDOSIS; DISEASE DURATION; DOSE RESPONSE; GLUCOSE BLOOD LEVEL; HUMAN; HYPOGLYCEMIA; INFECTION; INSULIN PUMP; INSULIN TREATMENT; META ANALYSIS; METABOLISM; RISK FACTOR; SOCIAL PSYCHOLOGY;

AGE FACTORS; BLOOD GLUCOSE; DIABETES MELLITUS, TYPE 1; ENVIRONMENTAL MONITORING; HUMANS; INSULIN INFUSION SYSTEMS; MEDLINE; RESEARCH DESIGN; SAMPLE SIZE;

EID: 0041666676     PISSN: 01495992     EISSN: None     Source Type: Journal    
DOI: 10.2337/diacare.26.4.1079     Document Type: Article

References (94)

1. Kitabchi AE, Fisher JN, Burghen GA, Gaylord MS, Blank NM: Evaluation of a portable insulin infusion pump for outpatient management of brittle diabetes. Diabetes Care 2:421-424, 1979
2. Pickup JC, White MC, Keen H, Parsons JA, Alberti KG: Long-term continuous subcutaneous insulin infusion in diabetics at home. Lancet 2:870-873, 1979
3. Tamborlane WV, Sherwin RS, Genel M, Felic P: Reduction to normal of plasma glucose in juvenile diabetes by subcutaneous administration of insulin with a portable infusion pump. N Engl J Med 300: 573-578, 1979
4. Diabetes Control and Complications Trial Research Group: The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med 329:977-985, 1993
5. UK Prospective Diabetes Study (UKPDS) Group: Intensive blood glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS33). Lancet 352:837-853, 1998
6. World Health Organization: Constitution of the World Health Organization. World Health Org., Geneva, 1948
7. Schiffrin AD, Belmonte MM: Comparison between continuous subcutaneous insulin infusion and multiple injections of insulin: a one-year prospective study. Diabetes 331:255-264, 1982
8. Tamborlane WV, Sherwin RS, Genel M, Felic P: Outpatient treatment of juvenile-onset diabetes with a preprogrammed portable subcutaneous insulin infusion system. Am J Med 68:190-196, 1980
9. Schiffrin AD, Desrosiers M, Alevassine H, Belmonte MM: Intensified insulin therapy in the type I diabetic adolescents: a controlled trial. Diabetes Care 7:107-113, 1984
10. Bell DS, Ovalle F: Improved glycemic control with use of continuous subcutaneous insulin infusion compared with multiple insulin injection therapy. Endocr Pract 6:357-360, 2000
11. Bode BW, Steed RD, Davidson PC: Reduction in severe hypoglycemia with long-term continuous subcutaneous insulin infusion in type 1 diabetes. Diabetes Care 19:324-327, 1996
12. Bougneres PF, Landier MD, Lemmel C, Mensire A, Chaussain JL: Insulin pump therapy in young children with type 1 diabetes. J Pediatr 105:212-217, 1984
13. Brambilla P, Artavia-Loria E, Chaussain JL, Bougneres PF: Risk of ketosis during intensive insulin therapy in pre-school-age diabetic children. Diabetes Care 10: 44-48, 1987
14. Calabrese G, Bueti A, Santeusanio F, Giombolini A, Zega G, Angeletti G, Cartechini MG, Brunetti P: Continuous subcutaneous insulin infusion treatment in insulin-dependent diabetic patients: a comparison with conventional optimized treatment in a long-term study. Diabetes Care 5:457-465, 1982
15. Chantelau E, Spraul M, Muhihauser I, Gause R, Berger M: Long-term safety, efficacy and side-effects of continuous subcutaneous insulin infusion treatment for type 1 (insulin-dependent) diabetes mellitus: a one centre experience. Diabetologia 32:421-426, 1989
16. Chantelau E, Schiffers T, Schutze J, Hansen B: Effect of patient-selected intensive insulin therapy on quality of life. Patient Educ Couns 30:167-175, 1997
17. Christensen CK, Christiansen JS, Christensen T, Hermansen K, Mogensen CE: The effect of six months continuous subcutaneous insulin infusion on kidney function and size in insulin-dependent diabetics. Diabet Med 3:29-32, 1986
18. Crawford LM, Sinha RN, Odell RM, Comi RJ: Efficacy of insulin pump therapy: mealtime delivery is the key factor. Endocr Pract 6:239-243, 2000
19. Felsing W, Bibergeil H, Menzel R, Albrecht G, Felsing U, Dabels J, Reichel G, Luder C: Results of treatment with continuous subcutaneous insulin infusion (CSII) in insulin-dependent (type 1) diabetics. Exp Clin Endocrinol 83:136-142, 1984
20. Foley-Nolan D, Foley-Nolan A, Temperley D, Devlin J: Diabetics treated with continuous subcutaneous insulin infusion pumps. Ir Med J 82:159-160, 1989
21. Greene SA, Smith MA, Baum JD: Clinical application of insulin pumps in the management of insulin dependent diabetes. Arch Dis Child 58:578-581, 1983
22. Grobe H, Seibold H, Ullrich K, Muller-Limmroth S, Ziegler R: Continuous subcutaneous insulin infusion in the treatment of insulin-dependent diabetes mellitus. Monatsschr Kinderheilkd 136:81-84, 1988
23. Guinn TS, Bailey GJ, Mecklenburg RS: Factors related to discontinuation of continuous subcutaneous insulin-infusion therapy. Diabetes Care 11:46-51, 1988
24. Haakens K, Hanssen KF, Dahl-Jorgensen K, Vaaler S, Aagen ES, Mosand R: Continuous subcutaneous insulin-infusion (CSII), multiple injections (MI) and conventional insulin therapy (CT) in self-selecting insulin-dependent diabetic patients: a comparison of metabolic control, acute complications and parent preferences. J Intern Med 228:457-464, 1990
25. Haug PJ, Kelly TM, Cannon RB, Edwards CQ: A self-controlled study of the effect of continuous subcutaneous insulin infusion on diabetic neuropathy. J Neurol Sci 82:123-132, 1987
26. Kelly TM, Sanborn GE, Haug PJ, Edwards CQ: Effect of insulin infusion pump use on diabetic retinopathy. Arch Ophthalmol 102:1156-1159, 1984
27. Kronert K, Hulser J, Luft D, Stetter T, Eggstein M: Effects of continuous subcutaneous insulin infusion and intensified conventional therapy on peripheral autonomic nerve dysfunction. J Clin Endocrinol Metab 64:1219-1223, 1987
28. Kuno T, Tasaki H, Miyazaki S: Continuous subcutaneous insulin injection for self-care of young patients with insulin-dependent diabetes mellitus. Acta Paediatr Jpn 38:464-469, 1996
29. Lager I, Attvall S, Blohme G, Smith U: Altered recognition of hypoglycaemic symptoms in type 1 diabetes during intensified control with continuous subcutaneous insulin infusion. Diabet Med 3:322-325, 1986
30. Leichter SB, Schreiner ME, Reynolds R, Bolick T: Long-term follow-up of diabetic patients using insulin infusion pumps: considerations for future clinical application. Arch Intern Med 145:1409-1412, 1985
31. Levy-Marchal C, Czernichow P: Feasibility of continuous subcutaneous insulin infusion in young diabetic patients. Diabete Metab 14:108-113, 1988
32. Lombardo A, Scavino S, Scornavacca G, Oliva G, Sipione C, Cacciola R, Motta L: Continuous subcutaneous insulin infusion: a long-term study. Acta Diabetol Lat 23:1-12, 1986
33. Maniatis AK, Klingensmith GJ, Slover RH, Mowry CJ, Chase HP: Continuous subcutaneous insulin infusion therapy for children and adolescents: an option for routine diabetes care. Pediatrics 107:351-356, 2001
34. Mecklenburg RS, Benson EA, Benson JW, Blumenstein BA, Fredlund P, Guinn TS, Metz RJ, Nielsen RL: Long-term metabolic control with insulin pump therapy: report of experience with 127 patients. N Engl J Med 313:465-468, 1985
35. Ronn B, Mathiesen ER, Vang L, Lorup B, Deckert T: Evaluation of insulin pump treatment under routine conditions. Diabetes Res Clin Pract 3:191-196, 1987
36. Sherwin RS, Tamborlane W, Genel M, Felig P: Treatment of juvenile-onset diabetes by subcutaneous infusion of insulin with a portable pump. Diabetes Care 3:301-308, 1980
37. Steindel BS, Roe TR, Costin G, Carlson M, Kaufman FR: Continuous subcutaneous insulin infusion (CSII) in children and adolescents with chronic poorly controlled type 1 diabetes mellitus. Diabetes Res Clin Pract 27:199-204, 1995
38. Strickland AL, Strickland J: An outpatient technique for continuous subcutaneous insulin infusion in adolescents and young adults with IDDM. J S C Med Assoc 96: 386-389, 2000
39. Tressanchez Trias JM, Mesa Manteca J, Sanmarti Sala AM, Obiols Alfonso G, Pujol Borrel R: Insulin-dependent diabetes mellitus: subcutaneous insulin therapy with a portable infusion pump. Med Clin (Barc) 80:394-397, 1983
40. Wieliczko MC, De Menibus CH, Mallet E: Insulin therapy using a portable pump in children: apropos of a pediatric experience. Ann Pediatr (Paris) 39:535-541, 1992
41. Wredling R, Lins PE, Adamson U: Factors influencing the clinical outcome of continuous subcutaneous insulin infusion in routine practice. Diabetes Res Clin Pract 19:59-67, 1993
42. Bak JF, Nielsen OH, Pedersen O, Beck-Nielsen H: Multiple insulin injections using a pen injector versus insulin pump treatment in young diabetic patients. Diabetes Res 6:155-158, 1987
43. Champion MC, Shepher GA, Rodger NW, Dupre J: Continuous subcutaneous infusion of insulin in the management of diabetes mellitus. Diabetes 29:206-212, 1980
44. Grimm JJ, Haardt MJ, Thibult N, Goicolea I, Tchobroutsky G, Slama G: Lifestyle, metabolic control and social implications of pump therapy in 54 routine type 1 diabetic patients. Diabete Metab 13:3-11, 1987
45. Hanaire-Broutin H, Melki V, Bessieres-Lacombe S, Tauber JP: The Study Group for the Development of Pump Therapy in Diabetes: comparison of continuous subcutaneous insulin infusion and multiple daily injection regimens using insulin lispro in type 1 diabetic patients on intensified treatment. Diabetes Care 23:1232-1235, 2000
46. Helve E, Koivisto VA, Lehtonen A, Pelkonen R, Huttunen J, Nikkila E: A crossover comparison of continuous insulin infusion and conventional injection treatment of type 1 diabetes. Acta Med Scand 221: 385-393, 1987
47. Home PD, Capaldo B, Burrin JM, Worth R, Alberti K: A crossover comparison of continuous subcutaneous insulin infusion (CSII) against multiple insulin injections in insulin-dependent diabetic subjects: improved control with CSII. Diabetes Care 5:466-471, 1982
48. Lecavalier L, Havrankova J, Hamet P, Chiasson J: Effects of continuous subcutaneous insulin infusion versus multiple injections on insulin receptors in insulin-dependent diabetics. Diabetes Care 10: 300-305, 1987
49. Marshall SM, Home PD, Taylor R, Alberti K: Continuous subcutaneous insulin infusion versus injection therapy: a randomized cross-over trial under usual diabetic clinic conditions. Diabet Med 4:521-525, 1987
50. Reeves ML, Seigler DE, Ryan EA, Skyler J: Glycemic control in insulin-dependent diabetes mellitus: comparison of outpatient intensified conventional therapy with continuous subcutaneous insulin infusion. Am J Med 72:673-680, 1982
51. Saurbrey N, Arnold-Larsen S, Moller-Jensen B, Kuhl C: Comparison of continuous subcutaneous insulin infusion with multiple insulin injections using the NovoPen. Diabet Med 5:150-153, 1988
52. Schmitz A, Christiansen JS, Christensen CK, Hermansen K, Mogensen C: Effect of pump versus pen treatment on glycemic control and kidney function in long-term uncomplicated insulin-dependent diabetes mellitus (IDDM). Dan Med Bull 36: 176-178, 1989
53. Schottenfeld-Naor Y, Galatzer A, Karp M, Josefsberg Z, Laron Z: Comparison of metabolic and psychological parameters during continuous subcutaneous insulin infusion and intensified conventional insulin treatment in type I diabetic patients. Isr J Med Sci 21:822-828, 1985
54. Beck-Nielsen H, Richelsen B, Schwartz Sorensen N, Hother Nielsen O: Insulin pump treatment: effect on glucose homeostasis, metabolites, hormones, insulin antibodies and quality of life. Diabetes Res 2:37-43, 1985
55. Bell D, Ackerson C, Cutter G, Clements R: Factors associated with discontinuation of continuous insulin infusion. Am J Med Sci 295:23-28, 1988
56. Bibergeil H, Huttl I, Felsing W, Felsing U, Seidlein I, Herfurth S, Dabels J, Reichel G, Luder C, Albrecht G, et al.: Thirty six months continuous subcutaneous insulin infusion (CSII) in insulin dependent diabetes (IDDM) - influence on early stages of retinopathy, nephropathy and neuropathy - psychological analysis. Exp Clin Endocrinol 90:51-61, 1987
57. Boland EA, Grey M, Oesterle A, Fredrickson L, Tamborlane W: Continuous subcutaneous insulin infusion: a new way to lower risk of severe hypoglycemia, improve metabolic control, and enhance coping in adolescents with type 1 diabetes. Diabetes Care 22:1779-1784, 1999
58. Dahl JS, Toriesen P, Hanssen K, Sandvik L, Aagenes O: Increase in insulin antibodies during continuous subcutaneous insulin infusion and multiple-injection therapy in contrast to conventional treatment. Diabetes 36:1-5, 1987
59. Edelmann E, Walter H, Biermann E, Schleicher E, Bachmann W, Mehnert H: Sustained normoglycemia and remission phase in newly diagnosed type 1 diabetic subjects: comparison between continuous subcutaneous insulin infusion and conventional therapy during a one year follow-up. Horm Metab Res 19:419-421, 1987
60. Goicolea Opacua I, Hernandez Colau I, Vazquez Garcia J: Comparative study between the subcutaneous continuous insulin infusion pump and optimized conventional treatment: effects at 6 months. Rev Clin Esp 179:3-7, 1986
61. Guerci B, Meyer L, Delbachian I, Kolopp M, Ziegler O, Drouin P: Blood glucose control on Sunday in IDDM patients: intensified conventional insulin therapy versus continuous subcutaneous insulin infusion. Diabetes Res Clin Pract 40:175-180, 1998
62. Knight G, Boulton A, Drury J, Ward J: Long term glycaemic control by alternative regimens in a feasibility study of continuous subcutaneous insulin infusion. Diabetes Res 3:355-358, 1986
63. Olsen T, Richelsen B, Ehlers N, Beck-Nielsen H: Diabetic retinopathy after 3 years' treatment with continuous subcutaneous insulin infusion (CSII). Acta Ophthalmol 85:185-189, 1987
64. Tubiana-Rufi N, de Lonlay P, Bloch J, Czernichow P: Remission of severe hypoglycemic incidents in youth. Arch Pediatr 3:969-976, 1996
65. Grizzle JE: The two-period change over design and its use in clinical trials. Biometrics 21:467-480, 1965
66. Reichard P, Nilson BY, Rosenquist U: The effect of long term intensified insulin treatment on the development of microvascular complications of diabetes mellitus. N Engl J Med 329:304-309, 1993
67. Zeger SL, Liang KY: Longitudinal data analysis for discrete and continuous outcomes. Biometrics 42:121-130, 1986
68. Mecklenburg RS, Benson JW, Becker NM, Brazel PL, Fredlund PN, Metz RJ, Nielsen RL, Sannar C, Steenrod W: Clinical sue of the insulin infusion pump in 100 patients with type 1 diabetes. N Engl J Med 307: 513-518, 1982
69. Nathan DM, Lou P, Avruch J: Intensive conventional and insulin pump therapies in adult type 1 diabetes: a crossover study. Ann Intern Med 97:31-36, 1982
70. Lauritzen T, Larsen HW, Frost-Larsen K, Deckert T: Effect of 1 year of near-normal blood glucose levels on retinopathy in insulin-dependent diabetics. Lancet 1:200-204, 1983
71. Schiffrin A, Desrosiers M, Mofflatt M, Belmonte M: Feasibility of strict diabetes control in insulin-dependent diabetic adolescents. J Pediatr 103:522-527, 1983
72. Mecklenburg RS, Benson EA, Benson JW, Fredlund P, Guinn T, Metz R, Nielsen R, Sanner C: Acute complications associated with insulin infusion pump therapy: report of experience with 161 patients. JAMA 252:3265-3269, 1984
73. Brink SJ, Stewart C: Insulin pump treatment in insulin-dependent diabetes mellitus: children, adolescents, and young adults. JAMA 255:617-621, 1986
74. Knight G, Boulton A, Ward JD: Experience of continuous subcutaneous insulin infusion in the outpatient management of diabetic teenagers. Diabet Med 3:82-84, 1986
75. Dusseldorf Study Group (Ziegler D, Dannehl K, Koschinsky T, Toeller M, Gries F): Comparison of continuous subcutaneous insulin infusion and intensified conventional therapy in the treatment of type 1 diabetes: a two-year randomized study. Diabetes Nutr Metab 3:203-213, 1990
76. Diabetes Control and Complications Trial: Implementation of treatment protocols in the diabetes control and complications trial. Diabetes Care 18:361-376, 1995
77. Kanc K, Janssen MM, Keulen E, Jacobs M, Popp-Snijders C, Snoek E, Heine R: Substitution of night-time continuous subcutaneous insulin infusion therapy for bedtime NPH insulin in a multiple injection regimen improves counterregulatory hormonal responses and warning symptoms of hypoglycaemia in IDDM. Diabetologia 41:322-329, 1998
78. Tsui E, Barnie A, Ross S, Parkes R, Zinman B: Intensive insulin therapy with insulin Lispro. Diabetes Care 24:1722-1727, 2001
79. Seigler DE, LaGreca A, Satin-Rappaport W, Reeves M, Skyler J: Psychological effects of intensification of diabetic control. Diabetes Care 5 (Suppl. 1):19-23, 1982
80. Shapiro J, Wigg D, Charles M, Perley M: Personality and family profiles of chronic insulin-dependent diabetic patients using portable insulin infusion pump therapy: a preliminary investigation. Diabetes Care 7:137-142, 1984
81. Connis RT, Taylor TR, Gordon MJ, Mecklenburg RS, Liljenquist JE, Stephens JW, Baker MS: Changes in cognitive and social functioning of diabetic patients following initiation of insulin infusion therapy. Exp Aging Res 15:51-60, 1989
82. Slijper FM, deBeaufort CE, Bruining GJ, deVisser J, Aarsen R, Dicken D, vanStrik R: Psychological impact of continuous subcutaneous insulin infusion pump therapy in non-selected newly diagnosed insulin dependent (type I) diabetic children: evaluation after two years of therapy. Diabete Metab 16:273-277, 1990
83. Kaufman FR, Halvorson M, Kim C, Pitukcheewanont P: Use of insulin pump therapy at nighttime only for children 7-10 years of age with type 1 diabetes. Diabetes Care 23:579-582, 2000
84. Pickup JC, Keen H, Viberti G, Bilous R: Patient reactions to long-term outpatient treatment with continuous subcutaneous insulin infusion. BMJ 282:766-768, 1981
85. Skyler JS, Seigler DE, Reeves M: A comparison of insulin regimens in insulin-dependent diabetes mellitus. Diabetes Care 5 (Suppl. 1):11-18, 1982
86. Floyd JC, Cornell RG, Jacober SJ, Griffith LE, Funnell MM, Wolf LL, Wolf FM: A prospective study identifying risk factors for discontinuance of insulin pump therapy. Diabetes Care 16:1470-1478, 1993
87. Wolf FM, Jacober SJ, Wolf L, Cornell RG, Floyd JC: Quality of life activities associated with adherence to insulin infusion pump therapy in the treatment of insulin dependent diabetes mellitus. J Clin Epidemiol 42:1129-1136, 1989
88. Lustman P, Anderson R, Freedland K, DeGroot M, Carney R, Clouse R: Depression and poor glycemic control: a meta-analytic review of the literature. Diabetes Care 23:934-942, 2000
89. Rubin R: Psychosocial Assessment in Core Curriculum for Diabetes Education. 3rd ed. Funnell M., Hunt C, Kulkarni K, Rubin R, Yarborough P, Eds. Chicago, American Association of Diabetes Educators, 1998
90. Johnson S: Health behavior and health status: concepts, methods and applications. J Ped Psychol 19:129-141, 1994
91. Hanson C: Developing systemic models of the adaptation of youths with diabetes. In Stress and Coping in Child Health. LaGreca A, Siegel L, Wallander J, Walker E, Eds. New York, Guilford, 1992, p. 212-241
92. Kotsanos J, Vignati L, Huster W, Andrejasich C, Boggs M, Jacobson A, Marrero D, Mathias S, Patrick D, Zalani S: Health related quality of life results from multinational clinical trials of insulin lispro: assessing benefits of new diabetes therapy. Diabetes Care 20:948-958, 1997
93. Anderson B, Ho J, Brackett J, Finkelstein D, Laffel L: Parental involvement in diabetes management tasks: relationships to blood glucose monitoring adherence and metabolic control in young adolescents with insulin-dependent diabetes mellitus. J Pediatr 130:257-265, 1997
94. Golin C, DiMatteo M, Gelberg L: The role of patient participation in the doctor visit: implications for adherence to diabetes care. Diabetes Care 19:1153-1164, 1996